198 related articles for article (PubMed ID: 23089459)
1. Lower mortality from nasopharyngeal cancer in The Netherlands since 1970 with differential incidence trends in histopathology.
Arnold M; Wildeman MA; Visser O; Karim-Kos HE; Middeldorp JM; Fles R; Bing Tan I; Coebergh JW
Oral Oncol; 2013 Mar; 49(3):237-43. PubMed ID: 23089459
[TBL] [Abstract][Full Text] [Related]
2. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China.
Jia WH; Huang QH; Liao J; Ye W; Shugart YY; Liu Q; Chen LZ; Li YH; Lin X; Wen FL; Adami HO; Zeng Y; Zeng YX
BMC Cancer; 2006 Jul; 6():178. PubMed ID: 16822324
[TBL] [Abstract][Full Text] [Related]
3. Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008.
Hollestein LM; de Vries E; Nijsten T
Eur J Cancer; 2012 Sep; 48(13):2046-53. PubMed ID: 22342554
[TBL] [Abstract][Full Text] [Related]
4. Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma.
Schuurman MS; van den Einden LC; Massuger LF; Kiemeney LA; van der Aa MA; de Hullu JA
Eur J Cancer; 2013 Dec; 49(18):3872-80. PubMed ID: 24011936
[TBL] [Abstract][Full Text] [Related]
5. Subtype Specific Nasopharyngeal Carcinoma Incidence and Survival Trends: Differences between Endemic and Non-Endemic Populations.
Argirion I; Zarins KR; Suwanrungruang K; Pongnikorn D; Chitapanarux I; Sriplung H; Vatanasapt P; Rozek LS
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3291-3299. PubMed ID: 33247687
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
Liu MT; Yeh CY
Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
[TBL] [Abstract][Full Text] [Related]
7. Tobacco smoking, alcohol drinking, and the risk of different histological types of nasopharyngeal cancer in a low-risk population.
Polesel J; Franceschi S; Talamini R; Negri E; Barzan L; Montella M; Libra M; Vaccher E; Franchin G; La Vecchia C; Serraino D
Oral Oncol; 2011 Jun; 47(6):541-5. PubMed ID: 21478046
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of EBV-related LMP-1, histologic type, and environmental factors in nasopharyngeal carcinoma in a German population.
Dietz A; Logothetis CA; Helbig M; Flechtenmacher C; Rudat V; Dollner R; Wallner F; Bosch FX
Onkologie; 2004 Aug; 27(4):345-50. PubMed ID: 15347888
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan.
Zhou Y; Nabeshima K; Koga K; Aoki M; Hayashi H; Hamasaki M; Iwasaki H
Oncol Rep; 2008 Jun; 19(6):1413-20. PubMed ID: 18497945
[TBL] [Abstract][Full Text] [Related]
10. Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: Focus on low-risk areas.
Carioli G; Negri E; Kawakita D; Garavello W; La Vecchia C; Malvezzi M
Int J Cancer; 2017 May; 140(10):2256-2264. PubMed ID: 28224615
[TBL] [Abstract][Full Text] [Related]
11. The 1-year mortality after radiotherapy for nasopharyngeal carcinoma: a population-based analysis.
Wu SG; Zhang WW; Wang J; Lian CL; He ZY; Rong YM; Lin Q
Future Oncol; 2019 Oct; 15(29):3357-3365. PubMed ID: 31411050
[No Abstract] [Full Text] [Related]
12. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
13. Modest improvement in 20 years of kidney cancer care in the Netherlands.
van de Schans SA; Aben KK; Mulders PF; Haanen JB; van Herpen C; Verhoeven RH; Karim-Kos HE; Oosterwijk E; Kiemeney LA
Eur J Cancer; 2012 Aug; 48(12):1822-30. PubMed ID: 22365640
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
Ling W; Cao SM; Huang QH; Li YH; Deng MQ
Ai Zheng; 2009 Jan; 28(1):57-9. PubMed ID: 19448418
[TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type.
Vaughan TL; Shapiro JA; Burt RD; Swanson GM; Berwick M; Lynch CF; Lyon JL
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):587-93. PubMed ID: 8824359
[TBL] [Abstract][Full Text] [Related]
16. Outcome of nasopharyngeal carcinoma in Finland: A nationwide study.
Ruuskanen M; Grenman R; Leivo I; Vahlberg T; Mäkitie A; Saarilahti K; Wigren T; Korpela M; Voutilainen L; Koivunen P; Irjala H; Minn H
Acta Oncol; 2018 Feb; 57(2):251-256. PubMed ID: 28686479
[TBL] [Abstract][Full Text] [Related]
17. A nation-wide epidemiological study on the risk of developing second malignancies in patients with different histological subtypes of nasopharyngeal carcinoma.
Ooft ML; van Ipenburg J; Braunius WW; Stegeman I; Wegner I; de Bree R; Overbeek LI; Koljenović S; Willems SM
Oral Oncol; 2016 May; 56():40-6. PubMed ID: 27086485
[TBL] [Abstract][Full Text] [Related]
18. Beta-2-microglobulin (beta 2M) as a tumor marker in nasopharyngeal carcinoma.
Lee JK; Tsai SC; Hsieh JF; Ho YJ; Sun SS; Kao CH
Anticancer Res; 2000; 20(6C):4765-8. PubMed ID: 11205215
[TBL] [Abstract][Full Text] [Related]
19. No incidence trends and no change in pathological proportions of nasopharyngeal carcinoma in Zhongshan in 1970-2007.
Wei K; Xu Y; Liu J; Zhang W; Liang Z
Asian Pac J Cancer Prev; 2010; 11(6):1595-9. PubMed ID: 21338202
[TBL] [Abstract][Full Text] [Related]
20. Nasopharyngeal carcinoma incidence and mortality in China, 2013.
Wei KR; Zheng RS; Zhang SW; Liang ZH; Li ZM; Chen WQ
Chin J Cancer; 2017 Nov; 36(1):90. PubMed ID: 29122009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
